Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

388 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Acute renal and hepatic failure due to accidental percutaneous absorption of 1,2-dichlorpropane contained in a commercial paint fixative.
Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Ardissino D, De Palma G, Bergamaschi E, Mutti A. Fiaccadori E, et al. Among authors: De Palma G. Nephrol Dial Transplant. 2003 Jan;18(1):219-20. doi: 10.1093/ndt/18.1.219. Nephrol Dial Transplant. 2003. PMID: 12480995 No abstract available.
Immunotherapy and metastic renal cell cancer.
Buzio C, De Palma G, Caminiti C, Cattabiani MA, Manenti L. Buzio C, et al. Among authors: De Palma G. Nephrol Dial Transplant. 1996 Sep;11(9):1890. Nephrol Dial Transplant. 1996. PMID: 8918650 Clinical Trial. No abstract available.
Effectiveness of very low doses of immunotherapy in advanced renal cell cancer.
Buzio C, De Palma G, Passalacqua R, Potenzoni D, Ferrozzi F, Cattabiani MA, Manenti L, Borghetti A. Buzio C, et al. Among authors: De Palma G. Br J Cancer. 1997;76(4):541-4. doi: 10.1038/bjc.1997.422. Br J Cancer. 1997. PMID: 9275034 Free PMC article. Clinical Trial.
[Biomarkers of effect and susceptibility to low doses of benzene].
De Palma G, Mutti A, Spatari G, Andreoli R, Mozzoni P, Carrieri M, Manno M, Apostoli P. De Palma G, et al. G Ital Med Lav Ergon. 2013 Oct-Dec;35(4):259-62. G Ital Med Lav Ergon. 2013. PMID: 24303707 Italian.
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines.
Alfieri RR, Galetti M, Tramonti S, Andreoli R, Mozzoni P, Cavazzoni A, Bonelli M, Fumarola C, La Monica S, Galvani E, De Palma G, Mutti A, Mor M, Tiseo M, Mari E, Ardizzoni A, Petronini PG. Alfieri RR, et al. Among authors: De Palma G. Mol Cancer. 2011 Nov 23;10:143. doi: 10.1186/1476-4598-10-143. Mol Cancer. 2011. PMID: 22111840 Free PMC article.
Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC).
Tiseo M, Andreoli R, Gelsomino F, Mozzoni P, Azzoni C, Bartolotti M, Bortesi B, Goldoni M, Silini EM, De Palma G, Mutti A, Ardizzoni A. Tiseo M, et al. Among authors: De Palma G. Lung Cancer. 2014 Feb;83(2):265-71. doi: 10.1016/j.lungcan.2013.12.001. Epub 2013 Dec 12. Lung Cancer. 2014. PMID: 24388705
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines.
Galetti M, Alfieri RR, Cavazzoni A, La Monica S, Bonelli M, Fumarola C, Mozzoni P, De Palma G, Andreoli R, Mutti A, Mor M, Tiseo M, Ardizzoni A, Petronini PG. Galetti M, et al. Among authors: De Palma G. Biochem Pharmacol. 2010 Jul 15;80(2):179-87. doi: 10.1016/j.bcp.2010.03.033. Epub 2010 Apr 2. Biochem Pharmacol. 2010. PMID: 20363215
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.
Tiseo M, Rossi G, Capelletti M, Sartori G, Spiritelli E, Marchioni A, Bozzetti C, De Palma G, Lagrasta C, Campanini N, Camisa R, Boni L, Franciosi V, Rindi G, Ardizzoni A. Tiseo M, et al. Among authors: De Palma G. Lung Cancer. 2010 Mar;67(3):355-60. doi: 10.1016/j.lungcan.2009.04.021. Epub 2009 May 26. Lung Cancer. 2010. PMID: 19473722
388 results
Jump to page
Feedback